Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Mutations
  Research Models
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Expert Opinion
  Ask the Expert
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APP Research Models

Updated 19 February 2008

back to Research Models Index

Viewing tips: Make your browser window wide enough to view the table, which should fit on most standard monitors. 

 
Name/
Symbol
Strain Name Transgene/
Promoter and Regulatory Elements
Genetic Background Behavioral 
Phenotype
Neurological 
Characteristics
Patents/ 
Availability
Primary 
Citation
APPArcSwe

Symbol: APP

Posted 02/19/08

C57BL/6J-CBA-F1 Human APP cDNA clone with artic mutation (E693G) and Swedish mutation (KM670/671N)/modified Kozak seq/murine Thy-1 promoter. Origin: C57BL/6J-CBA; Background: C57Bl/6J; Backcross five generations. Spatial learning deficits at 4-8 months of age in MWM. Inclusion of the Artic mutation results in enhanced accumulation of soluble Aβ aggregates, facilitated accumulation of Aβ inside neurons and more robust senile plaques. PCT WO2005/089539; Assignee BioArctic Neuroscience.
Non-commercial use:
Contact Lars Nilsson, lars.nilsson@pubcare.uu.se
Phone: +46 18 471 5039. fax: +46 18 471 4808
Uppsala University, Sweden

Commercial use:
Pär Gellerfors, BioArctic Neuroscience AB, Sweden
Phone: +46 8 695 6930
http://www.bioarctic.se

Lord et al., 2006
APPPS1

Symbol: APP

Posted 05/06/07

B6-Tg(Thy1-APPswe; Thy1-PS1 L166P) Pronuclei coninjected with Thy1-APPKM670/671NL and Thy1-PS1L166P constructs, integration site on the lower arm of chr 2 between 40 and 60 cM C57BL/6J N/A APPPS1 develops cerebral amyloidosis at 6-8 weeks, Aβ 42 >> Aβ 40. Contact Mathias Jucker, mathias.jucker@uni-tuebingen.de Radde et al., 2006
TetO-APPSwe/Ind (line 885)

Symbol: APP

Posted 01/31/07

B6C3-Tg(tetO-APPswe/ind)8-85Dbo/J Chimeric mo/hu APP695(Swe/Ind) x tetO/ C57BL/6J X C3HeJ F2. Origin founder line 85-5, male hemizygous x female B6C3F1/J. Hemizygous mice viable/fertile. Bigenic mice have 10-fold more activity. Activity abolished by rearing with doxycycline. Mo/huAPP protein at 10-30 fold over endogenous. Treatment with doxycycline inhibits APP expression by >95% and reduces Aβ production. Plaques at 6 months. The Jackson Lab, available, stock #006004. For research or non-commercial use only; tet-system licence may be required. Jankowsky et al., 2005
Amyloid β (A4) precursor protein-binding, family B, member 1 (Apbb 1)

Symbol: p97FE65

Posted 01/23/07

B6.129-Apbb1tm1Quhu/J 500bp frag with first 3 start codons in exon 2 replaced by PKG promoter neo-cassette/R1 ES cells/C57BL/6. Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl<+>; backcross C57BL/6J Gen >10. Viable and normal, no physical abnormalities. Null mice have slower learning rates in aversive/spatial memory tasks. p97 protein not expressed in null mice, p60 N-term truncated isoform four- to fivefold greater levels. The Jackson Lab, available, stock #005708 Wang et al., 2004
APPSWE (2576)

Symbol: APP

Updated 1/25/06

B6;SJL -Tg
(APPSWE)
2576Kha  
Human AP695
cDNA with KM670/671NL/
hamster prion protein gene promoter
C57BL/6. Currently breeding hemizygous males with B6SJLF1 females Memory deficits seen in 9-10 month old tg mice. Numerous Aβ plaques, oxidative lipid and glycoxidative damages  Patent: 5,877,399
Taconic Datasheet
Hsiao K et al., 1996
Human BACE

Symbol: BACE

Posted 6/13/2005

  Human wtBACE-1 cDNA /mouse Thy 1/microinjected DBA/C57BL/6 embryos. Origin: FVB. Background C57BL/J   Transgene expressed in neurons only. Line 16 had high expression of human BACE. Frozen embryos stored at Charles River Breeding Labs.
Contact: Michael Willem
Willem et al., 2004
APPSw

Symbol: APP

Posted 6/7/2005

Tg.AD147.71H Human APPK670N, M671L (Swedish), mThy1.2. Origin: C57BL/6, DBA/2. Backcrossed C57BL/6 for 3N, then intercrossed F13.   Amyloidosis in the 2nd year of life, Amyloidosis 4X more prominent in females than males. Congophilic plaques in cortex and hippocampus, brain Aβ42 levels are 10 fold lower than Aβ40 levels. Contact: Laurence Ozmen
Laurence.ozmen@roche.com
Richards et al., 2003
hAPPSw/Ind/Arctic

Symbol: APP

Posted 4/21/2005

  Arctic (E22G), Swedish, and Indiana mutations human APP/PDGFß promoter Origin: C57BL/6Hsd; Background C57BL/6J; Generation Arc6 - N5 and Arc48 - N3 Pending Arctic mice form amyloid plaques faster and more extensively than J20 mice, even though they had lower Aβ 1-42/1-40 ratios. Relative levels of hAPP and of the β-secretase-generated C99 fragment were lower in Arc6 and higher in Arc48 than in J20 mice. Contact Lennart Mucke
Lmucke@gladstone.ucsf.edu
Cheng et al., 2004
APPSw-NSE

Symbol: APP

Posted 2/5/2005

  CMVAPP695sw construct, containing APPsw695/rat pNSE-CAT promoter / NSE-APPsw with the prokaryotic sequence eliminated. Origin: C57BL/6 x DBA/2, Background C57BL/6, Backcross 5 generations At 12 months showed longer escape latencies and increased escape distances in water maze. At 12 months increased Aβ-42 staining without plaque formation. Tau phosphorylation enhanced, JNK and p38 activated. Cox-2 levels, Caspase-3 and TUNEL staining seen. Patent filing date: 11/4/02

Contact: Yong K Kim
kimyongkyu@hanmail.net
Hwang et al., 2004
APP695K612V or SβCK612V

Symbol: APP

Posted 12/18/2004

  Valine substituted for lysine at site of βAPP/cytomegalovirus enhancer and chicken β-actin promoter. OE C99 Origin: C57BL/6 x C3H. Backcrossed to C57BL/6 Generation 4 (1998)   No brain lesions or plaque formation. 9-13 month old mice show 5x expression of protein product in muscle. Dr. Lee-Way Jin. These mice are no longer available Jin et al., 1998
Down syndrome model; segmental trisomy 16

Symbol: Ts(1716)65Dn

Posted 10/26/2004

B6EiC3Sn a/A-Ts(1716)65Dn 3 copies of mouse APP/Translocation of distal end of mouse Chr 16 to Chr 17. Origin: C57Bl/6Jeicher×C3H/HeSnJ. N37 Mice live until adult age. Low birth weight, developmental delay, muscle trembling, male sterility, reduced learning. APP elevated in cerebral cortex. At 6 months, higher level of Aß in hippocampus and mice show decline in cholinergic phenotype and cognitive deterioration. The Jackson Lab, Stock #001924 Davisson et al., 1990
APP-C99 (tg13592)

Symbol:APP

Posted 10/2/04

  5 copies C99 of b-APP /cytomegalovirus enhancer/b-actin promoter /C57BL/6 x DBA/2 Crossed to C57BL/6J >10 Generations Mice exhibit hypoactivity and spatial learning deficit. From 6-12 months display Aβ-immunoreactive deposits within the skeletal muscle fibers. Availability: Contact Dr. Ken-ichiro Fukuchi Fukuchi et al., 1996
APPV642IKI

Symbol:APP

Posted 8/10/04

  APPV642I/ 'knock-in' technique of homologous recombination and Cre-loxP system/Clone R34C(30)-9. Origin: C57BL/6 x CBA and CD-1 Significant deterioration of long-term memory. Acquisition of spatial memory slightly affected, but no deterioration in short-term working memory. 2yr old mice show no neuritic plaques or neurofibrillary tangles, but increases in amount of β-amyloid Aβ42 (43) compared to Aβ40. US Patent Application No.60/482,021 and PCT/JP2004/002296

Availability: Contact Dr Masaaki Matsuoka
Kawasumi et al., 2004
A -R1.40

Symbol:APP

Posted 12/15/03

A.Cg -Tg
(APP)R1.40Lmb
YAC with 300 kb hAPPSwe gene/R1 ES cells. Origin: 129X1/SvJ x 129S1/Sv-+P+Tyr-cKitlS1-J/+ Background A/J, N12 N/A Under analysis Bruce Lamb Unpublished
B6 -R1.40

Symbol:APP

Posted 12/15/03

B6.Cg -Tg
(APP)R1.40Lmb
YAC with 300 kb hAPPSwe gene/R1 ES cells Origin: 129X1/SvJ x 129S1/Sv-+P+Tyr-cKitlS1-J/+ Background C57BL/6J, N22 N/A Highest-level Aβ 40/42 compared to D2-R1.40 and 129S1-R1.40 mice. Aβ deposits in frontal and parietal cortex of >1-year-old mice Bruce Lamb Lamb BT, et al., 1997
B6 -Py8.9

Symbol:APP

Posted 12/15/03

B6.Cg -Tg
(APP)Py8.9Lmb
YAC with 300 kb hAPP gene/R1 ES cells Origin: 129S2/SvPas Background C57BL/6J, N22 N/A Mice express hAPP transcripts and proteins at levels similar to endogenous mouse. No evidence of AD-type pathology Bruce Lamb Lamb BT et al, l993.
D2 -R1.40

Symbol:APP

Posted 12/15/03

D2.Cg -Tg
(APP)R1.40Lmb
YAC with 300 kb hAPPSwe gene/R1 ES cells Origin: 129X1/SvJ x 129S1/Sv-+P+Tyr-cKitlS1-J/+ Background DBA/2J, N22 N/A Lowest level of Aβ 40 and Aβ 42 compared to B6-R1 Bruce Lamb Lamb BT et al, 2003
129S1 -R1.40

Symbol:APP

Posted 12/15/03

129S1.Cg -Tg
(APP)R1.40Lmb
YAC with 300 kb hAPPSwe gene/R1 ES cells Origin: 129X1/SvJ x 129S1/Sv-+P+Tyr-cKitlS1-J/+ Background 129S1/SvImJ, N20 N/A Lower amts of APP CTFs, intermediate levels of Aβ40 and Aβ42 and equivalent levels of holo-APP compared to D2- and B6-R1.4 mice Bruce Lamb Lamb BT et al, 2003.
Amyloid β(A4) precursor-like
protein 2

Symbol:Aplp2

Updated 12/10/05

B6.129S7-Aplp2tm1Dbo/J inactivated Aplp2 gene by deleting 1.1kb segment/PGKneo cassette/AB2.1 ES cells. Origin: B6;129S7; Backcross C57BL/6J for 5 generations (7/01). No behavioral abnormalities No Aplp2 gene product (mRNA or protein) is detected. Available
See JAX datasheet: Stock#: 004142
von Koch et al., 1997
APPnull;
Amyloid β (A4) precursor protein

Symbol:App

Updated 12/10/05

B6.129S7-Apptm1Dbo/J Inactivated Mouse APP gene/ PGKneo targeting vector/AB2.1 ES cells. Origin B6;129S7. Backcross C57BL/6J. Homozygous mice are viable, no physical or behavioral abnormalities at birth. By 14 weeks decreased locomotor activity. At birth no App gene product detected,14 weeks the mice exhibit evidence of reactive gliosis. Available
See JAX datasheet Stock#: 004133
Zheng et al., 1995
APP -C100   Human APP695 cDNA Carboxy terminal 100 a.a./
dystrophin neural promoter
C58BL/6 x SJL  homozygous Tg showed significant deficits in cued, spatial and reversal performance.  age-dependent impairment of spatial learning. age-dependent neuronal and synaptic degeneration, irregular cytoplasmic accumulations of atypical secondary lysosomes, and an increased neurofilament concentration in unmyelinated axons 5,672,805,
5,849,999
,
5,894,078

Contact Rachael Neve

These mice are no longer available.

Neve RL et al., 1996
APP Flemish/
APPDutch
  Human APP770 cDNA with A682G/
Human APP770 cDNA with E693Q/
mouse thy-1 gene promoter
FVB/N differential glutamatergic responses, increased aggression, occasional spontaneous seizures and variable premature death significantly decrease α-secretase APP while increasing β-secretase cleaved C-terminal fragments. Aβ level remains low without formation of amyloid plaque. Unpatented

Contact Paul Van Dun

These mice are no longer available.

Kumar-Singh et al., 2000
B6 -J1-96

Symbol:APP

Updated 12/15/03
B6.Cg-Tg(APP)J1.96Lmb YAC with 300 kb hAPPSwe/London gene/J1 ES cells Origin: 129S4/SvJae; Background C57BL/6J, N22 N/A High levels of Aβ peptides in tg with Swe and London mutations. A total and 42/43 are elevated in tg with London mutation. Contact B.T. Lamb Lamb BT, et al., 1997
APP London V717I

Updated 5/27/05

  Human APP695 cDNA with V717I/
mouse thy-1 gene. The thymus specific regulatory elements in intron 3 are thereby deleted, making the resulting promoter "neuron-specific"
FVB/N decreased exploration, increased neophobicity, increased male aggressivity amyloid
plaques and cerebrovascular
angiopathy - onset 10-12 months, cholinergic fiber distortion
Unpatented

Contact Paul Van Dun

Moechars D et al., 1999
NORBA   signal peptide and 99 residues of CTF of bAPP under control of cytomegalovirum enhancer/chicken b-actin promoter. 2000 copies of bA-NOR b were microinjected into one pronucleus of fertilized B6C3F1 x C57BL/6N hybrid eggs N/A Aβ was detected biochemically in brain, kidney, and pancreas with the largest amount present in Pancreas. over 30 times Aβ accumulation in transgenic plasma than in normal human plasma. Contact Mikio Shoji Kawarabayashi et al., 1996
PDGF -APPWT
(See JAX datasheet)

Symbol:App

Updated 11/12/03

B6.Cg-Tg(PDGFB-APP)5Lm/J APPInd tg sequence converted to wildtype by PCR primer modification/PDGFB promoter/(v-sis) oncogene homolog. Origin:C57BL/6 X DBA/2 F1. Backcross C57BL/6J. Maintained as hemizygote   Transgene expression in cerebral neurons, neocortex and hippocampus, with total Aβ levels and 42 Aβ levels lower than in the APP SwInd mutant line. No amyloid plaques up to 24 months of age Available
The Jackson Lab Stock#: 004662
Mucke et al., 2000
PDAPP SwInd(J20)

Symbol:App

Updated 2/13/06

B6.Cg-Tg(PDGFB-APPSwInd)20Lms/J Tg construct: hAPPSwInd
Promotor: PDGFB
Injected: C57BL/6 x DBA/2F2 embryos
C57BL/6 X DBA/2 F1 mice WM spatial memory retention, acquisition, deficits 6-7 months (Palop et al., 2003) Total Aβ, and Aβ42 in neocortical and hippocampus High levels of Aβ(1-42) resulted in age-dependent formation of Aβ plaques in mutant hAPP mice but not wild-type hAPP mice Available
The Jackson Lab
Stock#:004661 (See JAX datasheet)
Mucke et al., 2000
PDGF -APPSwInd line J9

Updated 7/7/04

  The Swedish mutation was introduced into the PDGF-APPInd transgene. PDGF-APPSw, Ind transgene injected into (C57BL/6 × DBA/2) F2 one-cell embryos. C57BL/6 x DBA/2 F2 N/A 2-4 month old tg mice had almost twice as much A in their hippocampi, but much lower human APP levels than APPInd (line H6) tg mice. No amyloid plaques were detected yet electrophysiological recordings in hippocampal slice preparations detected synaptic transmission deficits.   Hsia et al., 1999
APP695 Line C3-3

Symbol: App695

Posted 2/12/07

C3B6-Tg(APP695)3Dbo/J B6C3H pronuclei were injected with cDNA encoding a chimeric APP695, with human gene mutations K595N, M596L, regulated by mouse prion promoter. Repository-cryopreserved Congenic mice with APPswe develop memory deficits Mice expressing this transgene develop amyloid deposits in brain tissue by 18-20 months of age. Available
The Jackson Lab
Stock#: 003375
Borchelt et al., 1996
APP/RK    Alpha Secretion cDNA with K687E, R684D/
mouse thy-1 gene promoter
FVB/N neophobic reaction, progressive CNS disorganization, premature death no change in NMDA receptor density or distribution. None of the typical hallmark of AD (Amyloid deposits, neurofibrillary tangles) Unpatented

Contact Paul Van Dun.

These mice are no longer available.

Moechars D et al., 1996 
TgAPPSwe-KI   humanized Aβ and introduced the K670N/M671L FAD mutation into a single transgenic line, exon 16. Outbred CD-1 N/A 9 fold greater than in normal human brain and nonamyloidogenic processing is depressed. Spatial and temporal expression patterns of human Aβ are reproduced.

Contact:
Dorothy Flood
or Steve Trusko

Reaume et al., 1996
APP751Swedish (APP14)

Symbol: APP

Updated 1/12/04

  APP751 Swedish /Human Thy-1 Origin: C57B6J
No abnormal behavior reported 2 fold overexpression of APP mRNA. No indication of AD pathology up to an age of 2 years.

Unpatented

Contacts:
Matthias Staufenbiel

Andrä et al., 1996
APP Swe/London (APP22)

Symbol: APP

Updated 1/12/04

  APP Swe/London/Human Thy-1 promoter Origin:C57B/6J
  2x over expression of APP mRNA. Diffuse Aβ deposits detected in neocortex and hippocampus at 18 months. Exhibit Neuritic changes, dystrophic cholinergic fibers and hyperphosphorylated tau.

Unpatented

Contact:
Matthias Staufenbiel

Sturchler-Pierrat et al., 1997
APP751 Swedish (APP23)

Symbol: APP

Updated 1o/30/05

  APP751Swedish/ murine Thy-1.2 Origin: C57BL/6J
Learning impairment in Morris water maze and a passive avoidance paradigm. 7x over expression of APP mRNA. A deposits at 6 months, by 24 months in neocortex and hippocampus. Inflammation, neuritic and synaptic degeneration and tau hyperphosphorylation. Evidence for Cerebral amyloid angiopathy (CAA).

Unpatented

Contact:
Matthias Staufenbiel

Sturchler-Pierrat et al., 1997
TgCRND8

Updated 10/30/05

  APPSwe/Ind (KM670/671NL+V717F)/
hamster prior promoter
Hybrid C3H/He-C57BL/6 At 3 months impairment in acquisition and learning reversal in memory version of the Morris water maze. Immunization against Aβ42 offset learning impairment (Janus). Aβ deposits at 3 months of age, by 10 weeks levels of Aβ40 and Aβ42 peptides 5-fold higher than endogenous Mo-APP. Dense-cored plaques and neuritic pathology evident from 5 months of age. Activated microglia appear concurrently with plaques. Contact:
David Westway

Chishti, MA et al., 2001
PDAPP(Line109)

Symbol:APP

Updated 10/30/05

  Minigene encoding codon717Valine to Phenylalanine mutation/modified hAPP introns 6,7,8 in construct resulted in expression of 770, 751 and 695 isoforms of human APP/PDGF-β promoter. SwissWebster x B6D2F1 (C57Bl/6 x DBA/2) Significant impairment on a variety of different learningand memory tests Aβ deposits, neuritic plaques, synaptic loss, astrocytosis and microgliosis 5,811,633
5,877,015
,

Contact:
Dora Games or Dale Schenk
Games et al., 1995; Rockenstein et al., 1995
hBACE

Symbol: APP

Posted 3/6/2005

  hBACE / MoPrP.Xho /a 15.9-kb NotI linear fragment Origin and background C57B6/C3H. Maintained as homozygous N/A BACE L, M and H express 7, 10 and 20-fold BACE over endogenous levels, respectively. No evidence of Aß deposition. Increased BACE expression in neuronal cell bodies, axons and synaptic elements of the hippocampus, puncta within the granule cell layer of the cerebellum, and neuropil within the spinal cord. Contact: Virginia M-Y Lee
vmylee@mail.med.upenn.edu
Lee et al., 2005
hBACE54

Symbol: BACE

Posted 8/10/04

  hBACE cDNA inserted into Xho1 of vector pTSCa1/murine Thy-1 promoter Origin: C57BL/6J; backcross >10 gen No major changes. Detailed analysis not yet performed hBACE mRNA ~ 4x higher than endogenous mRNA. Consistant hBACE protein expression in BACE54/4 line but variation in the Bace54/11 line. Highest protein in the cortex and hippocampus and lowest in the cerebellum. Contact Paolo Paganetti Bodendorf et al., 2002
Bace1 -/-
(See JAX datasheet)

Symbol: BACE

Updated 1/18/05

B6.129-Bacetm1Pcw/J Disrupted 2-kb of BACE 1 containing exon 1 (residues 1-87)/ replaced with a neomycin-resistance gene/transfected into R1 ES cells/ C57BL/6J blastocysts. Origin: C57BL/6 mice; Backcross 7 Gen. Viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. No gene product detected in brain tissue. Primary cultures of cortical neurons do not secrete amyloid β peptides (Aβ 1-40/42 or Aβ11-40/42) or beta C-terminal fragments ( CTFs). Available
The Jackson Lab:
Stock 004714
Cai et al., 2001
BACE1 Null     Normal Healthy, fertile and appear normal in gross anatomy, tissue histology.   Unpatented Luo Y et al

Copyright © 1996-2008 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad